Glaxo’s Caution on Vaccination Rate Recovery Raises Concern

Bookmark
(Bloomberg) -- GlaxoSmithKline Plc, the British pharmaceutical giant, said its 2020 earnings forecast is at risk if routine vaccination rates fail to recover after lockdowns caused by Covid-19.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.